Cargando…

Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study

BACKGROUND: Low-dose aspirin is widely recommended for patients at high risk for cardiovascular disease (CVD); however, it remains uncertain whether long-term treatment adversely affects renal function in patients with diabetes. We investigated whether long-term low-dose aspirin affects renal dysfun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Sadanori, Morimoto, Takeshi, Ogawa, Hisao, Sakuma, Mio, Soejima, Hirofumi, Nakayama, Masafumi, Jinnouchi, Hideaki, Waki, Masako, Akai, Yasuhiro, Ishii, Hitoshi, Saito, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726501/ https://www.ncbi.nlm.nih.gov/pubmed/26808136 http://dx.doi.org/10.1371/journal.pone.0147635

Ejemplares similares

Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management: A subanalysis of the JPAD trial
por: Okada, Sadanori, et al.
Publicado: (2011)

Low-Dose Aspirin Therapy in Patients With Type 2 Diabetes and Reduced Glomerular Filtration Rate: Subanalysis from the JPAD trial
por: Saito, Yoshihiko, et al.
Publicado: (2011)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Major risk factors for the appearance of white-matter lesions on MRI in hypertensive patients with controlled blood pressure
por: Takami, Takeshi, et al.
Publicado: (2012)

Cardiovascular and renal protective role of angiotensin blockade in hypertension with advanced CKD: a subgroup analysis of ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2018)

Reduction in hsCRP levels is associated with decreased incidence of cardiovascular events in Japanese hypertensive women but not in men
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2020)

Total adiponectin is associated with incident cardiovascular and renal events in treated hypertensive patients: subanalysis of the ATTEMPT-CVD randomized trial
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2019)

Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy
por: Okada, Sadanori, et al.
Publicado: (2020)

Febuxostat for Cerebral and CaRdiorenovascular Events PrEvEntion StuDy
por: Kojima, Sunao, et al.
Publicado: (2019)

Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ)
por: Ishii, Hitoshi, et al.
Publicado: (2018)

Development of a self‐efficacy questionnaire, ‘Insulin Therapy Self‐efficacy Scale (ITSS)’, for insulin users in Japanese: The Self‐Efficacy‐Q study
por: Nakaue, Junko, et al.
Publicado: (2018)

Correction to: Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ)
por: Ishii, Hitoshi, et al.
Publicado: (2018)

Incidence of lower limb amputation in people with and without diabetes: a nationwide 5-year cohort study in Japan
por: Kamitani, Fumika, et al.
Publicado: (2021)

Risk of Lactic Acidosis in Hospitalized Diabetic Patients Prescribed Biguanides in Japan: A Retrospective Total-Population Cohort Study
por: Mohri, Takako, et al.
Publicado: (2023)

The Burden of Preventable Adverse Drug Events on Hospital Stay and Healthcare Costs in Japanese Pediatric Inpatients: The JADE Study
por: Iwasaki, Hitoshi, et al.
Publicado: (2021)

Determinants of Myocardial Lactate Production During Acetylcholine Provocation Test in Patients With Coronary Spasm
por: Kaikita, Koichi, et al.
Publicado: (2015)

The Authors Reply:
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

An angiotensin II receptor blocker–calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone
por: Kim-Mitsuyama, Shokei, et al.
Publicado: (2013)

SiO(2) and TiO(2) nanoparticles synergistically trigger macrophage inflammatory responses
por: Tsugita, Misato, et al.
Publicado: (2017)

Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2012)

Correction: Combination Treatment of Rosuvastatin or Atorvastatin, with Regular Exercise Improves Arterial Wall Stiffness in Patients with Coronary Artery Disease
por: Toyama, Kensuke, et al.
Publicado: (2013)

Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study
por: Ishii, Hitoshi, et al.
Publicado: (2017)

Absolute risk of acute coronary syndrome after severe hypoglycemia: A population‐based 2‐year cohort study using the National Database in Japan
por: Nishioka, Yuichi, et al.
Publicado: (2019)

Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin‐changing study intending to gain patients' insights into insulin treatment with patient‐reported health outcomes in actual clinical treatments (INSIGHTs) study
por: Ishii, Hitoshi, et al.
Publicado: (2013)

Long-term efficacy and safety of rabeprazole in patients taking low-dose aspirin with a history of peptic ulcers: a phase 2/3, randomized, parallel-group, multicenter, extension clinical trial
por: Fujishiro, Mitsuhiro, et al.
Publicado: (2015)

The age of death in Japanese patients with type 2 and type 1 diabetes: A descriptive epidemiological study
por: Nishioka, Yuichi, et al.
Publicado: (2022)

Genomic Sequences of Uropathogenic Escherichia coli Strains with Various Fluoroquinolone Resistance Profiles
por: Okumura, Kayo, et al.
Publicado: (2020)

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)
por: Nakajima, Hiroki, et al.
Publicado: (2018)

Incremental Prognostic Significance of the Elevated Levels of Pentraxin 3 in Patients With Heart Failure With Normal Left Ventricular Ejection Fraction
por: Matsubara, Junichi, et al.
Publicado: (2014)

Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan
por: Nishioka, Yuichi, et al.
Publicado: (2020)

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study
por: Takahashi, Yasuo, et al.
Publicado: (2013)

Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study
por: Murayama, Hiroki, et al.
Publicado: (2018)

Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin
por: Doutremepuich, Christian
Publicado: (2012)

Appropriate definition of diabetes using an administrative database: A cross‐sectional cohort validation study
por: Nishioka, Yuichi, et al.
Publicado: (2021)

Variant Aldehyde Dehydrogenase 2 (ALDH2*2) Is a Risk Factor for Coronary Spasm and ST‐Segment Elevation Myocardial Infarction
por: Mizuno, Yuji, et al.
Publicado: (2016)

Crystal structure of (2-{[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl](5-methyl-2H-pyrrol-2-ylidene)methyl}-5-methyl-1H-pyrrolido-κ(2) N,N′)difluoridoboron
por: Morimoto, Yukio, et al.
Publicado: (2015)

H(2)FPEF score for predicting future heart failure in stable outpatients with cardiovascular risk factors
por: Suzuki, Satoru, et al.
Publicado: (2020)

Immunological effect of local ablation combined with immunotherapy on solid malignancies
por: Takahashi, Yusuke, et al.
Publicado: (2017)

Nuclear factor-kappa B influences early phase of compensatory lung growth after pneumonectomy in mice
por: Takahashi, Yusuke, et al.
Publicado: (2017)

Association between influenza and the incidence rate of new‐onset type 1 diabetes in Japan
por: Nishioka, Yuichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v3fba30r8vrk6jd262006hgtcj